Iterum Therapeutics (ITRM) Insider Trading & Ownership → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free ITRM Stock Alerts $1.58 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Iterum Therapeutics (NASDAQ:ITRM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.40%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$91,500.00Number OfInsiders Selling(Last 12 Months)0 Get ITRM Insider Trade Alerts Want to know when executives and insiders are buying or selling Iterum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ITRM Insider Buying and Selling by Quarter Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Iterum Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/22/2023Michael W DunneDirectorBuy25,000$1.40$35,000.00 11/22/2023Michael W DunneDirectorBuy20,000$2.03$40,600.00 11/20/2023Corey N FishmanCEOBuy10,000$1.59$15,900.00 (Data available from 1/1/2013 forward) ITRM Insider Trading Activity - Frequently Asked Questions Who is on Iterum Therapeutics's Insider Roster? The list of insiders at Iterum Therapeutics includes Brenton Karl Ahrens, Corey N Fishman, Judith M Matthews, Michael W Dunne, and Sailaja Puttagunta. Learn more on insiders at ITRM. What percentage of Iterum Therapeutics stock is owned by insiders? 5.40% of Iterum Therapeutics stock is owned by insiders. Learn more on ITRM's insider holdings. Which Iterum Therapeutics insiders have been buying company stock? The following insiders have purchased ITRM shares in the last 24 months: Corey N Fishman ($15,900.00), and Michael W Dunne ($97,800.00). How much insider buying is happening at Iterum Therapeutics? Insiders have purchased a total of 65,000 ITRM shares in the last 24 months for a total of $113,700.00 bought. Which Iterum Therapeutics insiders have been selling company stock? The following insiders have sold ITRM shares in the last 24 months: Brenton Karl Ahrens ($156,000.00), and Sailaja Puttagunta ($4,441.80). How much insider selling is happening at Iterum Therapeutics? Insiders have sold a total of 78,365 Iterum Therapeutics shares in the last 24 months for a total of $160,441.80 sold. More Insider Trading Tools from MarketBeat Related Companies: DURECT Insider Trades Oncternal Therapeutics Insider Trades Indaptus Therapeutics Insider Trades Bullfrog AI Insider Trades Sensei Biotherapeutics Insider Trades Biora Therapeutics Insider Trades Unity Biotechnology Insider Trades Cumberland Pharmaceuticals Insider Trades Acurx Pharmaceuticals Insider Trades Aileron Therapeutics Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:ITRM) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
